ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Sifrol ER 0,375 mg, Retardtabletten - 10 Tablette(n)
60057001 Boehringer Ingelheim (Schweiz) GmbH
Sifrol ER 0,375 mg, Retardtabletten10.06.2010
Original10.06.2010
Pramipexole (N04BC05) 
WHO-DDD 
01.08.10 Tablette(n)
01.08. 
B  
Yes 
IPCI
5.33Yes
    
10 %15.00
7680600570016Synthetika
4612102 
Composition
pramipexoli dihydrochloridum monohydricum 0.375 mg corresp. pramipexolum 0.262 mg, hypromellosum, maydis amylum, carbomerum 941, silica colloidalis anhydrica, magnesii stearas pro compresso.
Packungsbestandteile
Retard-Tabletten 
 
Active AgentDose
Pramipexoli Dihydrochloridum Monohydricum0.375 mg correspond Pramipexolum 0.262 mg
BAG: Active AgentDose
Pramipexoli Dihydrochloridum Monohydricum0.375 mg
 
Inactive agentsDose
Carbomerum941
Hypromellosum 
Magnesii Stearas pro Compresso 
Maydis Amylum 
Silica Colloidalis Anhydrica 
 
Source
Data was imported : 05.03.2020 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home